{
    "case_number": "CAC-UDRP-107465",
    "time_of_filling": "2025-04-07 12:01:50",
    "domain_names": [
        "tevaethiopharma.com"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Teva Pharmaceutical Industries Ltd."
    ],
    "complainant_representative": "SILKA AB",
    "respondent": [
        "Ibrahim Ghazali"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant was established in 1901. It is an internationally active pharmaceutical company and maintains a portfolio of about 3500 products, including generics, specialty and over the counter medicines. The Complainant has 48 manufacturing sites and about 37000 employees in 57 markets.<\/p>\n<p>The Complainant operates the domain names &lt;tevapharm.com&gt; registered in 1996, &lt;tevapharma.com&gt;, registered in 2000, and &lt;tevapharm.us&gt;, registered in 2002.<\/p>\n<p>The disputed domain name was registered on February 12, 2025. It resolves to a parked webpage with the text: <em>&ldquo;Welcome to TEVA PHARMA,&rdquo; &rdquo;Coming Soon,&rdquo; and &ldquo;We are Launching our New Website. We&rsquo;re working hard to give you the best experience! Please come back soon&rdquo;.<\/em><\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>COMPLAINANT<\/p>\n<p>The Complainant states that the disputed domain name is confusingly similar to its TEVA and TEVA PHARMA trademarks, which it includes in their entirety, and the two elements of the TEVA PHARMA trademark are separated by the insertion of the element &ldquo;ethio&rdquo;. According to the Complainant, the TEVA and TEVA PHARMA trademarks form the dominant element of the disputed domain name and are clearly recognisable in it.<\/p>\n<p>The Complainant asserts that the Respondent has no rights or legitimate interests in respect of the disputed domain name. It points out that the Respondent has no trademark rights for &ldquo;tevaethiopharma&rdquo; or any similar term, and it is not commonly known under it. The Complainant adds that the Respondent is not affiliated with the Complainant and has not been licensed to use the TEVA and TEVA PHARMA trademarks.<\/p>\n<p>The Complainant further submits that the Respondent has not used the disputed domain name in connection with a bona fide offering of goods or services and has not carried out any legitimate noncommercial or fair use of it. The Complainant notes that the disputed domain name resolves to a parked webpage stating <em>&ldquo;Coming Soon&rdquo; <\/em>under the heading <em>&ldquo;Welcome to TEVA PHARMA&rdquo;.<\/em><\/p>\n<p>The Complainant maintains that the disputed domain name carries a high risk of implied affiliation with the Complainant, because the combination of the TEVA and TEVA PHARMA trademarks with the term &ldquo;ethio&rdquo;, which could be viewed as a short form for &ldquo;Ethiopia&rdquo;, produces a misleading impression that the disputed domain name represents an entity in Ethiopia that has been authorized by or is affiliated with the Complainant.<\/p>\n<p>The Complainant contends that the disputed domain name was registered and is being used in bad faith. It maintains that the TEVA trademark is distinctive and enjoys a worldwide reputation, considering that products marked with it reach about 200 million people each day. The Complainant adds that the TEVA and TEVA PHARMA trademarks are easily identifiable in publicly accessible trademark databases, and a basic Google search for &ldquo;tevaethiopharma&rdquo; delivers results pertaining to the Complainant&rsquo;s TEVA brand. According to the Complainant, a basic due diligence review would have made any prospective registrant of the disputed domain name aware of the Complainant&rsquo;s rights in the globally-renowned TEVA brand.<\/p>\n<p>The Complainant maintains that the Respondent&rsquo;s specific awareness of and intention to target the Complainant is apparent from its subsequent parking of the disputed domain name with a <em>&ldquo;Coming Soon&rdquo; <\/em>webpage that directly references the TEVA PHARMA trademark in its heading <em>(&ldquo;Welcome to TEVA PHARMA&rdquo;). <\/em>According to the Complainant, it is inconceivable that the Respondent could have registered the disputed domain name without the specific intention of targeting the Complainant.<\/p>\n<p>The Complainant maintains that, given the prominence of the TEVA and TEVA PHARM trademarks in the disputed domain name and the risk of implied affiliation inherent to its composition, there is no conceivable good faith use to which the disputed domain name could be put by the Respondent without the consent of the Complainant.<\/p>\n<p>The Complainant lastly notes that the disputed domain name has been configured with MX (Mail Exchange) records. According to the Complainant, the configuration of MX records to the disputed domain name creates a risk that the Respondent may use it to engage in some form of phishing activities, and that Internet users receiving emails from an address at the disputed domain name may be misled to believe that they are receiving correspondence from an entity representing or associated with the Complainant, and may provide their sensitive information.<\/p>\n<p><\/p>\n<p>RESPONDENT<\/p>\n<p>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Respondent accessed the online platform and requested additional 4 calendar days to provide a response under Paragraph 5(b) of the UDRP Rules. The deadline was prolonged accordingly but the Respondent did not submit any response and no further communication from the Respondent was received by the Provider.<\/p>\n<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Assen Alexiev"
    ],
    "date_of_panel_decision": "2025-05-07 00:00:00",
    "informal_english_translation": "<p>The Complainant is the owner of a number of trademark registrations for &ldquo;TEVA&rdquo; (the &ldquo; TEVA trademark&rdquo;), including the following representative registrations:<\/p>\n<p>&minus; the United States trademark TEVA with registration No. 1567918, registered on 28 November 1989 for goods in International Class 5; and<\/p>\n<p>&minus; the European Union trademark TEVA with registration No. 001192830, registered on 18 July 2000 for goods in International Classes 3, 5 and 10.<\/p>\n<p>The Complainant is also the owner of the French trademark TEVA PHARMA with registration No. 3256982, registered on 14 November 2003 for goods and services in International Class 5 (the &ldquo;TEVA PHARMA trademark&rdquo;).<\/p>",
    "decision_domains": {
        "tevaethiopharma.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}